Literature DB >> 16523294

Choroidal vein and artery occlusion following photodynamic therapy in eyes with pathologic myopia.

Kyoko Ohno-Matsui1, Muka Moriyama, Kengo Hayashi, Manabu Mochizuki.   

Abstract

PURPOSE: To describe highly myopic patients in which either the large choroidal veins or arteries were occluded following PDT treatment.
METHODS: Demographic features of two highly myopic patients in which large choroidal vessels were occluded at 1 week following PDT, among a total of 23 patients who received PDT due to choroidal neovascularization (CNV) caused by high myopia, were demonstrated.
RESULTS: In case 1, ICG angiography demonstrated the complete occlusion of several large choroidal veins within the laser-applied area at 1 week after PDT. In case 2, ICG angiography demonstrated an occlusion of choroidal artery emanating from beneath the CNV. One month after PDT, re-perfusion of the occluded choroidal vessels was noted in both patients.
CONCLUSION: Occlusion of choroidal veins has never been reported in eyes with CNV treated by verteporfin therapy. Although further studies are necessary, occlusion of large choroidal vessels might happen in highly myopic eyes more commonly than expected. ICG angiography at 1 week after PDT was useful to evaluate the impact of PDT on large choroidal vessels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16523294     DOI: 10.1007/s00417-006-0303-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  8 in total

1.  The effect of axial length on laser spot size and laser irradiance.

Authors:  M Stur; S Ansari-Shahrezaei
Journal:  Arch Ophthalmol       Date:  2001-09

2.  Choroidal infarction following photodynamic therapy with verteporfin.

Authors:  Christina M Klais; Michael D Ober; K Bailey Freund; Leonard H Ginsburg; Alan Luckie; Martine Mauget-Faÿsse; Gabriel Coscas; Nicole E Gross; Lawrence A Yannuzzi
Journal:  Arch Ophthalmol       Date:  2005-08

3.  Time course and morphology of vascular effects associated with photodynamic therapy.

Authors:  Ursula Schmidt-Erfurth; Marc Niemeyer; Wolfgang Geitzenauer; Stephan Michels
Journal:  Ophthalmology       Date:  2005-12       Impact factor: 12.079

4.  Indocyanine green angiographic features of pathologic myopia.

Authors:  M Quaranta; J Arnold; G Coscas; C Français; G Quentel; D Kuhn; G Soubrane
Journal:  Am J Ophthalmol       Date:  1996-11       Impact factor: 5.258

5.  Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

Authors:  Kevin J Blinder; Mark S Blumenkranz; Neil M Bressler; Susan B Bressler; Guy Donato; Hilel Lewis; Jennifer I Lim; Ugo Menchini; Joan W Miller; Jordi M Mones; Michael J Potter; Constantin Pournaras; Al Reaves; Philip Rosenfeld; Andrew P Schachat; Ursula Schmidt-Erfurth; Michel Sickenberg; Lawrence J Singerman; Jason S Slakter; H Andrew Strong; Gianni Virgili; George A Williams
Journal:  Ophthalmology       Date:  2003-04       Impact factor: 12.079

6.  Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.

Authors:  D S C Lam; W-M Chan; D T L Liu; D S P Fan; W W Lai; K K L Chong
Journal:  Br J Ophthalmol       Date:  2004-10       Impact factor: 4.638

7.  Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy.

Authors:  Timothy Y Y Lai; Wai-Man Chan; Dennis S C Lam
Journal:  Am J Ophthalmol       Date:  2004-05       Impact factor: 5.258

8.  Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.

Authors:  Ursula Schlötzer-Schrehardt; Arne Viestenz; Gottfried O H Naumann; Horst Laqua; S Michels; Ursula Schmidt-Erfurth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-08-27       Impact factor: 3.117

  8 in total
  5 in total

1.  Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Amy L Wong; David T L Liu; Dennis S C Lam
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

2.  Intravitreal bevacizumab versus photodynamic therapy for myopic choroidal neovascularization in a North-African population.

Authors:  Leila El Matri; Fedra Kort; Ahmed Chebil; Rim Bouraoui; Ahlem Merdassi; Mejda Bouladi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-12       Impact factor: 3.117

3.  Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia.

Authors:  H Sakaguchi; Y Ikuno; F Gomi; M Kamei; M Sawa; M Tsujikawa; Y Oshima; S Kusaka; Y Tano
Journal:  Br J Ophthalmol       Date:  2006-08-16       Impact factor: 4.638

4.  Chorioretinal anastomosis after photodynamic therapy for polypoidal choroidal vasculopathy: CRA after PDT for PCV.

Authors:  Yuko Yodoi; Akitaka Tsujikawa; Atsushi Otani; Hiroko Aikawa; Nagahisa Yoshimura
Journal:  Int Ophthalmol       Date:  2007-08-15       Impact factor: 2.031

5.  Low-fluence-rate photodynamic therapy to treat subfoveal choroidal neovascularization in pathological myopia. A study of efficacy and safety.

Authors:  Gianluca Besozzi; Luigi Sborgia; Claudio Furino; Nicola Cardascia; Rosanna Dammacco; Giancarlo Sborgia; Andrea Palma Modoni; Francesco Boscia
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.